ISEC Healthcare Valuation

Q: What is the Fair Price of 40T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

40T (SGD0.39) is trading below our estimate of [[fair value]] (SGD0.47)

Is 40T undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 40T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 40T (SGD0.39) is trading below our estimate of fair value (SGD0.47)

Significantly Below Fair Value: 40T is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 40T?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 40T. This is calculated by dividing 40T's market cap by their current preferred multiple.
What is 40T's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	S$224.33m

40T key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.1x
Enterprise Value/EBITDA	11.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 40T's PE Ratio compare to its peers?

The above table shows the PE ratio for 40T vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	41.7x
5WA OUE Healthcare	49.2x	n/a	S$120.0m
EHG Econ Healthcare (Asia)	8.4x	n/a	S$53.2m
A50 Thomson Medical Group	82.2x	14.4%	S$1.3b
BSL Raffles Medical Group	26.8x	12.6%	S$1.6b
40T ISEC Healthcare	16.2x	n/a	S$224.3m

Price-To-Earnings vs Peers: 40T is good value based on its Price-To-Earnings Ratio (16.2x) compared to the peer average (41.7x).

Price to Earnings Ratio vs Industry

How does 40T's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 40T is good value based on its Price-To-Earnings Ratio (16.2x) compared to the Asian Healthcare industry average (23.1x).

Price to Earnings Ratio vs Fair Ratio

What is 40T's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

40T PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	16.2x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 40T's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.